GPUs/TPUs are essentially to CPUs what human-executed experiments are to automated ones. Trading capability for throughput, more or less via brute force. TPUs specifically were enabled by realizing a factory of shitty compute units worked very well for some applications.
IMO we’ve over invested in many technologies with highly speculative values. Engineering and logistics efforts towards reducing the cost of bulk RNAseq, or the costs of generating the clinical/animal/cellular the technology is applied to, for example, would have been a better use of $ than everything that’s been poured into single-cell methods development/commercialization.
@PghPhageProgram@DariaVanTyne do this routinely on a shoestring budget, ~>300 cases to date.
I don't think improved design is an "unlock" here--$ waiting for anyone that succeeds is the limiter. Please steer AI towards figuring out solutions for inf. disease market issues.
Sorta cool that this was done with some improvements in the design approach.
Readers may not realize there are groups already doing the work of generating substantial human data and treating patients with phage cocktails through compassionate use!
Read more from @carlzimmer in @NYTimes: https://t.co/AZXRu7oX7S
How Omnii-1 designed the phage: https://t.co/SoyZSQPUMb
Explore Omnii-1 and eight distinct applications, from cancer vaccines to biodefense https://t.co/NytTh6PEsH
@AaronBlotnick@AppleHelix How do you decouple the effects of culling of pre-pivotal small pharma from what you’re proposing? The null: lab space usage patterns are no different than before and are explained by lack of $$ flowing to lab space-intensive activities.
Tried to price a workflow on Ginkgo cloud lab today but found that client samples are not accepted--only commercially available reagents/inputs.
This leaves a very narrow possibility space. Any plans to change this @OmicsOmicsBlog@jrkelly ?
NEW on the SPRIND 🎧 #Podcast:
What are microbial consortia? And what is the SPRIND challenge Engineering Microbial Consortia all about? Our host speaks with: Joe Meyerowitz, serial entrepreneur and mastermind behind our new challenge.
Episode #136 of the SPRIND Podcast.
NEW on the SPRIND 🎧 #Podcast:
What are microbial consortia? And what is the SPRIND challenge Engineering Microbial Consortia all about? Our host speaks with: Joe Meyerowitz, serial entrepreneur and mastermind behind our new challenge.
Episode #136 of the SPRIND Podcast.